Original document(11 pages)  中文版
    The present invention relates to the application of (minus or plus)-7-(3,5,6-trimethyl-1,4-benzoquinone-2)-7- phenyl heptoic acid ester and amide compound as thromboxane A2/prostaglandin H2 acceptor antagonist in treating bronchial asthma, chronic obstructive pulmonary tuberculosis and allergic rhinitis.
Application Number
申请号		 01120596 Application Date
申请日		 2001.07.26
Title 名称 New substituted heptoic acid derivative for treating bronchial asthma and chronic obstructive pulmonary tuberculosis
Publication Number
公开号		 1398586 Publication Date
公开日		 2003.02.26
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/165,A61K31/216,A61P11/00,A61P11/02,A61P11/06,A61P37/08
Applicant(s) Name
申请人		 Inst. of Radiomedicine, Academy of Military Medical Sciences, PLA
Address 地址 100850
Inventor(s) Name 发明人 Gao Qixiu, Chen Zhengying
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application
Amine derivative with K channel regulation function and its preparing process and application
Application of new benzothiophene compound in preventing and treating women's post-menopause syndrome and other estrogen relative diseases
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.